JP2024533067A5 - - Google Patents
Info
- Publication number
- JP2024533067A5 JP2024533067A5 JP2024512096A JP2024512096A JP2024533067A5 JP 2024533067 A5 JP2024533067 A5 JP 2024533067A5 JP 2024512096 A JP2024512096 A JP 2024512096A JP 2024512096 A JP2024512096 A JP 2024512096A JP 2024533067 A5 JP2024533067 A5 JP 2024533067A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- seq
- composition according
- activated anti
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306272.2 | 2021-09-15 | ||
| EP21306272 | 2021-09-15 | ||
| PCT/EP2022/075608 WO2023041622A1 (en) | 2021-09-15 | 2022-09-15 | Selection of responders for anti-btn3a treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024533067A JP2024533067A (ja) | 2024-09-12 |
| JP2024533067A5 true JP2024533067A5 (cg-RX-API-DMAC7.html) | 2025-09-24 |
Family
ID=77998935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024512096A Pending JP2024533067A (ja) | 2021-09-15 | 2022-09-15 | 抗ｂｔｎ３ａ治療に対するレスポンダーの選択 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230227558A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4401837A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024533067A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118475611A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202313695A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023041622A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021001268A (es) * | 2018-08-01 | 2021-09-08 | Imcheck Therapeutics Sas | Anticuerpos anti-btn3a y su uso en el tratamiento del cáncer o trastornos infecciosos. |
| IL322506A (en) * | 2023-02-23 | 2025-10-01 | Imcheck Therapeutics | Combinations of BTN3A activating antibody and immune checkpoint inhibitors |
| TW202506731A (zh) * | 2023-04-27 | 2025-02-16 | 法商感應檢查療法公司 | 治療多重抗藥性細菌感染之方法 |
| WO2024251981A1 (en) * | 2023-06-09 | 2024-12-12 | Umc Utrecht Holding B.V. | Detecting and/or modulating susceptibility to btn2a1 and/or btn3a1 targeting therapeutics |
| EP4731681A1 (en) * | 2023-06-23 | 2026-04-29 | Imcheck Therapeutics | Bispecific antibodies targeting btn3a and the pd-1/pd-l1 inhibitory axis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0368684B2 (en) | 1988-11-11 | 2004-09-29 | Medical Research Council | Cloning immunoglobulin variable domain sequences. |
| WO2012080769A1 (en) | 2010-12-15 | 2012-06-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Anti-cd277 antibodies and uses thereof |
| MX2021001268A (es) | 2018-08-01 | 2021-09-08 | Imcheck Therapeutics Sas | Anticuerpos anti-btn3a y su uso en el tratamiento del cáncer o trastornos infecciosos. |
-
2022
- 2022-09-14 TW TW111134773A patent/TW202313695A/zh unknown
- 2022-09-15 CN CN202280062098.6A patent/CN118475611A/zh active Pending
- 2022-09-15 WO PCT/EP2022/075608 patent/WO2023041622A1/en not_active Ceased
- 2022-09-15 JP JP2024512096A patent/JP2024533067A/ja active Pending
- 2022-09-15 EP EP22801343.9A patent/EP4401837A1/en active Pending
-
2023
- 2023-03-14 US US18/183,588 patent/US20230227558A1/en active Pending